NEW YORK, NY – New stents with a biodegradable polymer are superior to first-generation drug-eluting stents (DES) when it comes to reducing target vessel revascularization (TVR) but are not better ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio SAN FRANCISCO — Data presented at TCT ...

Biodegradable magnesium stents have been developed to treat blockages in coronary arteries which can degrade within four months and achieve the same results as conventional stents, conclude authors of ...

New research published in Communications Biology and led by the University of Pittsburgh is poised to drastically improve the use of stents, demonstrating for the first time the successful use of a ...

Orlando, FL - Studies exploring the potential of drug-eluting and biodegradable stents are proliferating almost as fast as the cellular processes they are striving to keep in check, if the American ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. SAN DIEGO – Sharp Memorial is the first ...

WASHINGTON, DC—Two DES with biodegradable polymers—the everolimus-eluting Synergy and the sirolimus-eluting Orsiro—provide 1-year results not worse than those seen with the zotarolimus-eluting ...

Earlier drug-eluting stents were coated with non-biodegradable polymers and had thick stainless steel struts -- both features that have been linked with an increased rate of complications. In contrast ...

MUNICH — Results from three studies presented at the European Society of Cardiology Congress found that biodegradable stents and bioresorbable scaffolds are effective for reducing the risk for target ...

New research is poised to drastically improve the use of tracheal stents for children with airway obstruction. Researchers demonstrate for the first time the successful use of a completely ...

The first fully biodegradable stent implanted in human patients shows major adverse event rates similar to those of bare-metal stents (BMS) and overall acceptable long-term safety out to 10 years, ...